CD8A and neoplasm: Changes in CD8+ T cell distribution within the tumor microenvironment have been identified as a factor for proper immunotherapy response in multiple cancer models 58-61 with non-responsive lesions exhibiting a more peripheral and dispersed localization of this immune population.